Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation

PHASE3CompletedINTERVENTIONAL
Enrollment

422

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Heart DiseaseArrhythmiaAtrial Fibrillation
Interventions
DRUG

Olmesartan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

lead

Atrial Fibrillation Network

OTHER